MedPath

MYOFLEX ULTRA STRENGTH

MYOFLEX ULTRA STRENGTH

Discontinued
DIN Number

02226014

Drug Class

Human

Market Date

Mar 5, 1997

Company
HC

bayer inc consumer care

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02226014
AIG Number0103740004
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
M02AC PREPARATIONS WITH SALICYLIC ACID DERIVATIVES
Product Specifications
Dosage FormCream
Route of AdministrationTopical
AHFS Classification28:08.04.24
Health Canada Classification

ACTIVE INGREDIENTS (1)

TROLAMINE SALICYLATEActive
Strength: 20 %
Monograph: TROLAMINE SALICYLATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.